Paul Calabresi Career Development Award for Clinical Oncology (K12)

The summary for the Paul Calabresi Career Development Award for Clinical Oncology (K12) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Paul Calabresi Career Development Award for Clinical Oncology (K12)
	CFDA Number:	93.395
	CFDA Description:	Cancer Treatment Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Education Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PAR-10-155
	Document Type:	Modification to Previous Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Mar 26, 2010
	Creation Date:	Mar 26, 2010
	Original Closing Date for Applications:	Jul 10, 2013
	Current Closing Date for Applications:	Jun 11, 2012
	Archive Date:	Jul 11, 2012
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Grant Description: Purpose: This funding opportunity announcement (FOA) issued by the National Cancer Institute (NCI) encourages applications for institutional research career development (K12) programs from applicant organizations that propose to promote the training and career development of translational and clinical trials researchers. The purpose of the Paul Calabresi Career Development Award in Clinical Oncology (PCACO) K12 (NIH Institutional Research Career Development K12 grant mechanism) is to increase the number of clinicians (M.D.s, D.O.s, Pharm.D.s) and basic research scientists (Ph.D.s. or equivalents) who are trained to design and administer hypothesis-based pilot/Phase I, Phase II, and Phase III cancer therapeutic clinical trials in team research settings. A PCACO can support the research career development of clinicians only (single-track program) or clinicians and Ph.D. basic research scientists (dual-track program). Clinical and basic research scientists will collaborate and interact to expedite the translation of basic science research discoveries into patient-oriented therapeutic cancer research. The PCACO is not intended to train laboratory-based scientists whose research will be primarily focused upon the use of animal or other model systems. Mechanism of Support: This FOA will use the NIH Institutional Research Career Development K12 grant mechanism. K12 programs may not be transferred from one institution to another (See section VI.2). Funds Available and Anticipated Number of Awards: The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. Awards are renewable.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/par-10-155.html
Grant Announcement Contact: NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Childhood Cancer Survivor Study (CCSS)(Limited Competition U24); • Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Core Clinical Centers (U10); • Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Data Coordinating Center (U10); • Cancer Immunotherapy Trials Network (U01); • Developmental Projects in Complementary Approaches to Cancer Care and Treatment (R03); • Breast and Prostate Cancer Data Quality and Patterns of Care Study; • CONSORTIUM THERAPEUTIC STUDIES OF PRIMARY CENTRAL NERVOUS SYSTEM MALIGNANCIES IN ADULTS; • NATIONAL COOPERATIVE DRUG DISCOVERY GROUPS FOR CANCER; • Pediatric Phase 1/Pilot Consortium (U01); • Advanced Technology Radiation Therapy Clinical Trials Support (ATC) (Limited Competition U24)